Administration of intraliposomal CP20961 to mice activates peritoneal macrophages and augments serum antibody response to Toxoplasma gondii.
Mack
D
D
Dept. of Med., Michael Reese Hosp. and Med. Center, Chicago, IL.
Estes
R
R
McLeod
R
R
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood*; D003959:Diamines / Q000008:administration & dosage*; D005260:Female; D008081:Liposomes; D008262:Macrophage Activation / Q000187:drug effects*; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000276:immunology; D051379:Mice; D014677:Pharmaceutical Vehicles; D014122:Toxoplasma / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000913:Antibodies, Protozoan; D003959:Diamines; D008081:Liposomes; D014677:Pharmaceutical Vehicles; C006270:avridine